Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-
125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non …

Aggressive B‐cell lymphomas present as a heterogeneous spectrum of disease. A primary
diagnosis in the bone marrow (BM) may be challenging in terms of diagnostic classification …

Background. Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous non-Hodgkin's
lymphoma with great clinical challenge. Machine learning (ML) has attracted substantial …

The purpose of the present study was to evaluate the newest status of patients diagnosed
Burkitt lymphoma (BL), an aggressive lymphoma subset with a high cure rate. Furthermore …

Primary bone marrow lymphoma (PBML) is a disease entity in which lymphoma primarily
originates in the bone marrow without signs of involvement of lymph nodes, spleen, liver, or …

Diffuse large B-cell lymphoma (DLBCL) is well known for selectively involving certain
extranodal locations such as the central nervous system (CNS), testes, and skin. DLBCL or …

Primary bone marrow diffuse large B-cell lymphoma is an exceedingly rare form of non-
Hodgkin lymphoma. It may demonstrate a leukemic presentation, and a proportion of cases …

Background: Primary bone marrow diffuse large B-cell lymphoma (PBM-DLBCL) is a rare
hematological malignancy with a poor prognosis. The lack of a clear definition and unified …

Systemic osteosclerosis is a rare complication of hematological malignancies. Primary
myelofibrosis and acute megakaryocytic leukemia are known as underlying diseases; …

Objective: Rare disease Background: Hodgkin lymphoma is a type of lymphoid neoplasm
characterized by the presence of Reed-Sternberg cells in histopathology. It presents with …